Effects of volatile anesthetics, enflurane, isoflurane, and halothane on ventricular delayed activation in a canine myocardial infarction model

Imamura, Satoshi; Hashimoto, Hisakuni; Ikeda, Kazuyuki; Nakashima, Mitsuyoshi

doi:10.1016/s0022-0736(05)80109-8

Cited by 2 publications

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…90 Further data suggest that halothane shows similar and comparable effects on ventricular activation to those of enflurane. 91 The clinical relevance is questionable, however, as one study showed enflurane increased the QTc interval significantly after start of anesthesia but with no marked influence on inducibility of clinical ventricular tachycardias. 92…”

Section: Probable Associationmentioning

confidence: 99%

Clinical Relevance and Management of Drug‐Related QT Interval Prolongation

2003

View full text Add to dashboard Cite

Much attention recently has focused on drugs that prolong the QT interval, potentially leading to fatal cardiac dysrhythmias (e.g., torsade de pointes). We provide a detailed review of the published evidence that supports or does not support an association between drugs and their risk of QT prolongation. The mechanism of drug-induced QT prolongation is reviewed briefly, followed by an extensive evaluation of drugs associated with QT prolongation, torsade de pointes, or both. Drugs associated with QT prolongation are identified as having definite, probable, or proposed associations. The role of the clinician in the prevention and management of QT prolongation, drug-drug interactions that may occur with agents known to affect the QT interval, and the impact of this adverse effect on the regulatory process are addressed.

show abstract

Section: Probable Associationmentioning

confidence: 99%